Navigation Links
AMA's New HIV Testing Guidelines Good for Public Health, Says AHF
Date:11/16/2007

Policy Calls for Wider Routine Testing, Improved Patient Privacy Protections

LOS ANGELES, Nov. 16 /PRNewswire-USNewswire/ -- AIDS Healthcare Foundation (AHF) today lauded the American Medical Association (AMA) for recently updating its HIV testing policy to include guidelines supporting wider routine testing and improved protection of patient privacy. According to a news item in the Kaiser Family Foundation's Daily HIV/AIDS Report, the AMA's new guidelines call for, "...physicians to routinely test consenting adult patients for HIV."

The AMA's move dovetails with a landmark revision in the Centers for Disease Control's (CDC) own HIV testing recommendations that were issued in September 2006. The CDC now encourages U.S. medical providers to make HIV testing a "routine part of care in health care settings for all patients ages 13 through 64," and encourages linkages to care and treatment for those found to be HIV infected. The CDC also suggests that, "(HIV)... screening should be routine, regardless of whether the patient is known or suspected to have specific behavioral risks for HIV infection."

"Making HIV testing a routine part of health care is key to controlling and reducing the number of undiagnosed individuals and will ultimately help us break the chain of news infections, " said Homayoon Khanlou, Chief of Medicine, US, for AIDS Healthcare Foundation. "These new AMA guidelines are a significant step toward a more prudent and practical public-health-minded approach to HIV testing, and I would strongly encourage medical providers everywhere to quickly adapt and implement these new guidelines into their own practices and delivery of medical care."

"More than one million people in the US are currently infected with HIV; about half do not consistently receive medical care, and one quarter of the total do not even know they are infected," said Whitney Engeran, III, Director, Public Health Division, for AIDS Healthcare Foundation. "While the new AMA and CDC guidelines are welcomed steps to promoting HIV testing as a routine part of medical care, there is still a lot more work to be done toward fully incorporating HIV testing into routine medical care. AHF worked successfully this year with the California Medical Association and other groups to get California's legislature to pass landmark legislation overhauling the state's HIV testing process, which removed the requirements for cumbersome, written informed consent. Unfortunately, other states have rejected similar legislation intended to streamline and improve testing while still protecting an individual's rights. Despite the work that remains, these new AMA guidelines will definitely be good for the public health."

About AHF

AIDS Healthcare Foundation (AHF) is the US' largest non-profit HIV/AIDS healthcare, research, prevention and education provider. AHF currently provides medical care and/or services to more than 61,000 individuals in 18 countries worldwide in the US, Africa, Latin America/Caribbean and Asia. Additional information is available at http://www.aidshealth.org


'/>"/>
SOURCE AIDS Healthcare Foundation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Study says COPD testing is not measuring up
2. Spirometry Testing for COPD Underused
3. Medical Services International Inc. Completes Testing for European Union (EU) Application
4. Medical Services International Received Its First Order for Testing By Regulatory Agencies in the United States
5. Lab-on-chip testing for bird flu developed by Singapore scientists
6. Physicians Wellness Network Announces Lab Testing Services for Consumers built on Microsoft HealthVault
7. PSA Testing Still Valuable for Prostate Cancer
8. Schwarzenegger Signs Bill to Remove Written Informed Consent for HIV Testing; "Most Important Change in Public HIV/AIDS Policy in Years," Says AHF
9. Latinos/Hispanics Across the Nation Recognize National Latino AIDS Awareness Day and Call to Action Leaders in Promoting HIV Testing, Prevention and Access to Care
10. Random drug testing not reliable in keeping teen athletes from using
11. Hepatitis C Testing Recommended for Anyone with a Tattoo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... PORT RICHEY, Fla. (PRWEB) , ... February 27, 2017 , ... ... use disorder, but concern for women who become dependent on opioid painkillers has fallen ... among female patients, compared to a 237% increase in fatal overdoses in male populations.(1) ...
(Date:2/27/2017)... ... ... Orange County dentist, Dr. A. Rassouli, comments on the new ... bacteria in plaque infect the gums and other tissues supporting the teeth. Treatment typically ... SRP, and can include surgical therapies if the condition has led to significant damage. ...
(Date:2/27/2017)... ... ... POUGHKEEPSIE, N. Y. – Peer-reviewed guidelines from the International Lyme and Associated ... Disease Control ( CDC ) and Infectious Diseases Society of America (IDSA) dismiss any ... into a single volume a compelling argument that the disease does exist in his ...
(Date:2/27/2017)... Francisco, CA (PRWEB) , ... February 27, 2017 ... ... center for hair transplantation therapy, is proud to announce a new informational post ... hair therapy procedures. Follicular Unit Extraction (FUE) hair transplant and Follicular Unit Transplantation ...
(Date:2/26/2017)... ... February 25, 2017 , ... The February 13, 2017, assassination of ... concern over nerve agents and the deadly use of chemical weapons. Many questions exist ... how even small doses can be lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... 2017   Royal Philips (NYSE: ... in health technology, today announced 510(k) clearance from ... market its ElastQ Imaging capability, further expanding the ... ElastQ Imaging enables simultaneous imaging of tissue and ... the diagnosis of various liver conditions. With ElastQ ...
(Date:2/27/2017)... 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... focused on tissue protection, repair and regeneration, today ... Ltd., received a positive response from the U.S. ... for RGN-137 to treat epidermolysis bullosa ("EB"). RGN-137 ... Thymosin beta 4 ("Tß4") as the active pharmaceutical ...
(Date:2/27/2017)... , Feb. 27, 2017  CTI BioPharma Corp. (CTI BioPharma) ... Adam Craig , M.D., Ph.D., as President and Chief Executive ... March 20, 2017. Dr. Craig succeeds Richard Love , ... the company,s Board of Directors.  Dr. Craig has over 20 ... both the US and Europe . ...
Breaking Medicine Technology: